European Heart Journal· 2022Q1· Guideline
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- 3,719citations
- Q1SCImago
- 2022year
Short summary
The 2022 ESC/ERS guidelines introduce a new risk stratification model for pulmonary hypertension (PH) that incorporates clinical, echocardiographic, and biomarkers to predict 1-year mortality, aiming to improve treatment decisions.
AI-generated from the title and abstract; the full text is not read.
Key points
- Introduces a novel risk stratification model for pulmonary hypertension (PH) to predict 1-year mortality.
- Integrates clinical, echocardiographic, and biomarker data for enhanced predictive accuracy.
- Emphasizes a multidisciplinary approach to PH management.
- Highlights the importance of early diagnosis and risk assessment.
AI-generated from the title and abstract; the full text is not read.
Abstract
All experts involved in
The authors' abstract, as published at the source. European Heart Journal, 2022 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pulmonary and Respiratory Medicine
Pulmonary and Respiratory MedicineMedicine